Cannabix Technologies Competitors

Cannabix Technologies (CNSX:BLO) and Canopy Growth (TSE:WEED) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, profitability, dividends, analyst recommendations, valuation and institutional ownership.

Profitability

This table compares Cannabix Technologies and Canopy Growth's net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Cannabix Technologies and Canopy Growth's revenue, earnings per share and valuation.

Cannabix Technologies has higher earnings, but lower revenue than Canopy Growth.

Analyst Recommendations

This is a summary of recent ratings and price targets for Cannabix Technologies and Canopy Growth, as reported by MarketBeat.

Canopy Growth has a consensus target price of C$38.46, indicating a potential upside of 11.88%.

Summary

Canopy Growth beats Cannabix Technologies on 1 of the 1 factors compared between the two stocks.

Leaf Mobile (TSE:LEAF) and Cannabix Technologies (CNSX:BLO) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, risk, valuation, institutional ownership, earnings, analyst recommendations and profitability.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Leaf Mobile and Cannabix Technologies, as reported by MarketBeat.

Leaf Mobile presently has a consensus target price of C$0.75, indicating a potential upside of 94.81%.

Valuation and Earnings

This table compares Leaf Mobile and Cannabix Technologies' top-line revenue, earnings per share (EPS) and valuation.

Cannabix Technologies has lower revenue, but higher earnings than Leaf Mobile.

Profitability

This table compares Leaf Mobile and Cannabix Technologies' net margins, return on equity and return on assets.

Summary

Leaf Mobile beats Cannabix Technologies on 2 of the 2 factors compared between the two stocks.

OrganiGram (TSE:OGI) and Cannabix Technologies (CNSX:BLO) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, risk, valuation, institutional ownership, earnings, analyst recommendations and profitability.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for OrganiGram and Cannabix Technologies, as reported by MarketBeat.

OrganiGram presently has a consensus target price of C$3.77, indicating a potential upside of 19.24%.

Valuation and Earnings

This table compares OrganiGram and Cannabix Technologies' top-line revenue, earnings per share (EPS) and valuation.

Cannabix Technologies has lower revenue, but higher earnings than OrganiGram.

Profitability

This table compares OrganiGram and Cannabix Technologies' net margins, return on equity and return on assets.

Summary

OrganiGram beats Cannabix Technologies on 2 of the 2 factors compared between the two stocks.

Emblem (CVE:EMC) and Cannabix Technologies (CNSX:BLO) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, risk, valuation, institutional ownership, earnings, analyst recommendations and profitability.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Emblem and Cannabix Technologies, as reported by MarketBeat.

Valuation and Earnings

This table compares Emblem and Cannabix Technologies' top-line revenue, earnings per share (EPS) and valuation.

Cannabix Technologies has lower revenue, but higher earnings than Emblem.

Profitability

This table compares Emblem and Cannabix Technologies' net margins, return on equity and return on assets.

Summary

Emblem beats Cannabix Technologies on 1 of the 1 factors compared between the two stocks.

ICC Labs (CVE:ICC) and Cannabix Technologies (CNSX:BLO) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, valuation and risk.

Earnings & Valuation

This table compares ICC Labs and Cannabix Technologies' gross revenue, earnings per share (EPS) and valuation.

ICC Labs has higher revenue and earnings than Cannabix Technologies.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for ICC Labs and Cannabix Technologies, as provided by MarketBeat.com.

Profitability

This table compares ICC Labs and Cannabix Technologies' net margins, return on equity and return on assets.

Summary

ICC Labs beats Cannabix Technologies on 1 of the 1 factors compared between the two stocks.

Cannabix Technologies (CNSX:BLO) and (CMED.TO) (TSE:CMED) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, risk, earnings, analyst recommendations and profitability.

Valuation and Earnings

This table compares Cannabix Technologies and (CMED.TO)'s gross revenue, earnings per share and valuation.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Cannabix Technologies and (CMED.TO), as provided by MarketBeat.com.

Profitability

This table compares Cannabix Technologies and (CMED.TO)'s net margins, return on equity and return on assets.